ARTICLE | Clinical News
Promedior preclinical data
September 13, 2010 7:00 AM UTC
In a mouse model of fungal-induced allergic airway disease, Pentraxin-2 led to markedly less inflammation, improved lung function and significantly reduced mucus production and fibrosis vs. saline-tre...